assay Archives | Be Korea-savvy
A New T-Cell Activation Assay Based on Hyris qPCR Technology Marks a Disruptive Approach for the Detection of SARS-CoV-2 Specific Cellular Immunity

A New T-Cell Activation Assay Based on Hyris qPCR Technology Marks a Disruptive Approach for the Detection of SARS-CoV-2 Specific Cellular Immunity

LONDON, June 15 (Korea Bizwire) — With over 460 million global cases thus far, 6 million of which have resulted in death, the COVID-19 pandemic from SARS-CoV-2 proved to be a dire health crisis on a global scale. In this concerning scenario, the unprecedented effort by the international scientific community is even more remarkable and led [...]

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

BOULDER, Colo., Nov. 16 (Korea Bizwire) — InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its new ArrayMaxTM Mixer to provide significantly reduced assay times for its VaxArray® Portfolio of immunoassay kits. Current VaxArray Assays include kits for influenza, coronavirus, measles/rubella, [...]

Beroni Group to Launch its Advanced US FDA-Approved Virus Diagnostic Kit to Help Combat Global Outbreaks of Zika, Dengue, Chikungunya and West Nile Viruses

Beroni Group to Launch its Advanced US FDA-Approved Virus Diagnostic Kit to Help Combat Global Outbreaks of Zika, Dengue, Chikungunya and West Nile Viruses

NEW YORK and SYDNEY, Australia, Oct. 24 (Korea Bizwire) — In April 2019, Beroni Group Limited (“Beroni” or the “Company”) (NSX: BTG; OTCQX: BNIGF) signed an exclusive license agreement with Columbia University whereby Columbia University grants to Beroni and its affiliates, an exclusive license to distribute the patented CII-ArboViroPlex rRT-PCR assay on a worldwide basis. The CII-ArboViroPlex [...]

Invivoscribe® Releases LymphoTrack® TRB Assay on MiSeq® and LymphoTrack® Minimal Residual Disease (MRD) Software

Invivoscribe® Releases LymphoTrack® TRB Assay on MiSeq® and LymphoTrack® Minimal Residual Disease (MRD) Software

SAN DIEGO, Nov. 7 (Korea Bizwire) — Invivoscribe® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized molecular medicine®, announces the release of the Research Use Only (RUO) version of its LymphoTrack® TRB Assay for the Illumina MiSeq® platform. Included with the assay is [...]

Invivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit

Invivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit

SAN DIEGO, Aug. 1 (Korea Bizwire) — Invivoscribe® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized molecular medicine®, today announces the release of the CE-marked IVD version of its LeukoStrat® CDx FLT3 Mutation Assay which earlier this year was approved by [...]